Know Cancer

or
forgot password
  • cancer clinical trials in houston, TX

  • Study of Late-Occurring Complications in Childhood Cancer Survivors
    M D Anderson Cancer Center
    Houston, Texas 77030
    Cancer Survivor, Cardiovascular Complications, Hematopoietic/Lymphoid Cancer, Unspecified Childhood Solid Tumor, Protocol Specific
    Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor
    Texas Children's Cancer Center and Hematology Service at Texas Children's Hospital
    Houston, Texas 77030-2399
    Brain and Central Nervous System Tumors
    Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131
    M D Anderson Cancer Center
    Houston, Texas 77030
    Recurrent Thyroid Cancer, Stage IVA Follicular Thyroid Cancer, Stage IVA Papillary Thyroid Cancer, Stage IVB Follicular Thyroid Cancer, Stage IVB Papillary Thyroid Cancer, Stage IVC Follicular Thyroid Cancer, Stage IVC Papillary Thyroid Cancer
    Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
    Baylor University Medical Center - Houston

    Trial Locations
    Baylor University Medical Center - Houston
    M. D. Anderson Cancer Center at University of Texas
    Brain Tumor, Central Nervous System Tumor
    Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors
    University of Texas M.D. Anderson CCOP Research Base
    Houston, Texas 77030-4009
    Chemotherapy-induced Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific, Breast Cancer, Gastrointestinal Cancer, Disease (or Disorder); Gynecological, Prostate Cancer
    Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    M.D. Anderson Cancer Center at University of Texas
    Houston, Texas 77030
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    RAD001 in Recurrent Endometrial Cancer Patients
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Endometrial Cancer
    PANVACâ„¢-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen
    Dr. H. Alejandro Preti, F.A.C.P.

    Trial Locations
    Dr. H. Alejandro Preti, F.A.C.P.
    Elkins Pancreas Center
    Pancreatic Cancer
    Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma
    MD Anderson Cancer Center at University of Texas
    Houston, Texas 77030-4009
    Melanoma (Skin)
    Trial of Curcumin in Advanced Pancreatic Cancer
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Pancreatic Neoplasms, Adenocarcinoma
    Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer
    M. D. Anderson Cancer Center at University of Texas

    Trial Locations
    M. D. Anderson Cancer Center at University of Texas
    Dan L. Duncan Cancer Center at Baylor College of Medicine
    Bladder Cancer
    Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma
    University of Texas M.D. Anderson CCOP Research Base
    Houston, Texas 77030-4009
    Lymphoma
    Sarasar and Temodar for Glioblastoma Multiforme Patients
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Glioblastoma Multiforme, Gliosarcoma, Brain Tumors
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    M. D. Anderson Cancer Center at University of Texas
    Houston, Texas 77030-4009
    Breast Cancer
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Baylor University Medical Center - Houston

    Trial Locations
    Baylor University Medical Center - Houston
    M. D. Anderson Cancer Center at University of Texas
    Leukemia
    Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer
    M. D. Anderson Cancer Center at University of Texas
    Houston, Texas 77030-4009
    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    Methodist Hospital

    Trial Locations
    Methodist Hospital
    M D Anderson Cancer Center
    Lyndon Baines Johnson General Hospital
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme
    M. D. Anderson Cancer Center at University of Texas
    Houston, Texas 77030-4009
    Brain and Central Nervous System Tumors
    Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Multiple Myeloma
    Baylor University Medical Center - Houston

    Trial Locations
    Baylor University Medical Center - Houston
    M. D. Anderson Cancer Center at University of Texas
    Methodist Hospital
    Multiple Myeloma and Plasma Cell Neoplasm
    Scleroderma: Cyclophosphamide or Transplantation (SCOT)
    MD Anderson Cancer Center

    Trial Locations
    MD Anderson Cancer Center
    University of Texas-Houston Medical School
    Scleroderma, Systemic, Sclerosis, Autoimmune Disease
    Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML
    The University of Texas MD Anderson Cancer Center
    Houston, Texas 77030-4009
    Myeloid Leukemia, Chronic, Chronic-Phase
    Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML
    The University of Texas MD Anderson Cancer Center
    Houston, Texas 77030-4009
    Myeloid Leukemia, Chronic, Accelerated Phase, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
    Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer
    M D Anderson Cancer Center
    Houston, Texas 77030
    Recurrent Skin Cancer, Squamous Cell Carcinoma of the Skin
    Sorafenib Tosylate With or Without Recombinant Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer
    M D Anderson Cancer Center
    Houston, Texas 77030
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Vaccine Therapy in Treating Patients With Malignant Melanoma
    M.D. Anderson Cancer Center at University of Texas
    Houston, Texas 77030
    Melanoma (Skin)
    Phase II Nilotinib With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML)
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Leukemia, Myelogenous, Chronic
    Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis
    M. D. Anderson Cancer Center at University of Texas
    Houston, Texas 77030-4009
    Liver Cancer
    Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
    Michael E. DeBakey VA Medical Center (152)
    Houston, Texas 77030
    Prostate Cancer
    Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
    Baylor College of Medicine

    Trial Locations
    Baylor College of Medicine
    M D Anderson Cancer Center
    Localized Osteosarcoma, Metastatic Osteosarcoma
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    Ben Taub General Hospital

    Trial Locations
    Ben Taub General Hospital
    Methodist Hospital
    St. Luke's Texas Cancer Institute at St. Luke's Episcopal Hospital
    Metastatic Cancer, Prostate Cancer
    An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Patients (Male or Female ≥18 Years) With Ph + CML in Blast Crisis
    MD Anderson Cancer Center
    Houston, Texas 77030-4096
    Philadelphia Positive Chronic Myeloid Leukemia in Myeloid Blast Crisis
    An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Adult Patients With Ph + Leukemia
    MD Anderson Cancer Center, University of Texas
    Houston, Texas 77030
    Philadelphia Positive Chronic Myeloid Leukemia in Accelerated Phase, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
    An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Adult Patients With Ph + Leukemia
    MD Anderson Cancer Center, University of Texas
    Houston, Texas 77030
    Philadelphia Positive Chronic Myeloid Leukemia in Accelerated Phase, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
    Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors
    Memorial Hermann Hospital
    Houston, Texas 77030
    Neuroendocrine Cancer, Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Gastric Cancer
    Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas Cancer
    Memorial Hermann Hospital
    Houston, Texas 77030
    Pancreatic Neoplasms
    Chemotherapy With Whole Body Hyperthermia to Treat Resistant Breast, Endometrial, Cervical and Ovarian Cancers
    Memorial Hermann Hospital
    Houston, Texas 77030
    Breast Neoplasms, Endometrial Neoplasms, Cervix Neoplasms, Ovarian Neoplasms
    Docetaxel Alone or in Combination With Vaccine to Treat Breast Cancer
    U.T.M.D. Anderson Cancer Center
    Houston, Texas 77030
    Breast Cancer
    Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer
    M.D. Anderson Cancer Center
    Houston, Texas 77030
    Thyroid Cancer
    Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement
    Texas Children's Cancer Center
    Houston, Texas 77030-2399
    NEUROBLASTOMA
    U19 Project 1 (Targretin Effect on Breast Cancer)
    Baylor Breast Center
    Houston, Texas 77030
    Breast Cancer